Answers are grounded in this paper and cite their sources.
Orthotopic liver transplantation (OLT) offers the best chance for cure in the setting of unresectable hepatocellular carcinoma (HCC). A consensus statement recommends locoregional therapy (LRT) be considered in patients with HCC who are expected to wait more than 6 months for OLT to diminish dropout from the waiting list because of tumor progression. This article reviews LRT as a bridge to OLT in patients with HCC.
No takes yet. Share an insight, caveat, or question.
Prasad et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: